NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1841286721 MD
Verify on CMS → Maleka Ahmed, MD
Medical Oncology Physician in Lumberton, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 228 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$523.94
23 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Maleka Ahmed, MD filed 1,351 Medicare Part D claims in 2024 as a Medical Oncology Physician in Lumberton, North Carolina, prescribing 76% generic.
- 1K
- Part D claims, 2024
- 76%
- generic prescribing
- $523.94
- industry payments (Sunshine Act)
- ≥79th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Maleka Ahmed, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1841286721), first enumerated 09/26/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,351 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$523.94 in reported industry payments (23 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1841286721 · Medical Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1841286721
- ENUM-LEGACY 2005
- TAX-NARROW 4,028
- RX-MID 1,351
- BOOK-THIN 108 in North Carolina
- PHOTO-ENUM Alan Campbell · 2005
Maleka Ahmed, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,351 ≥ 79th percentile 79% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Maleka Ahmed, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Maleka Ahmed, MD?
Quality data not reportedPrimary specialty
Medical Oncology Physician
Medicare Part D claims
1,351 85% vs specialty avg
Specialty distribution in North Carolina
How Medical Oncology Physician compares to other specialties among North Carolina providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Medical Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1841286721 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 09/26/2005 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Maleka Ahmed, MD. Source: openpaymentsdata.cms.gov.
Total received
$524
Largest payer
Aveo Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Maleka Ahmed, MD - brand share 24.0%
Medical Oncology Physician average
24% brand-name claims vs 76% generic, on 1,351 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,351
Total Claims
$4.8M
Total Drug Cost
228
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,781.833
- Total Day Supply
- 47,709
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $4.1M
- Generic Drug Cost
- $684K
- Opioid Claims
- 134 (9.9% rate)
- Antibiotic Claims
- 27
Patient Demographics
- Average Patient Age
- 72.2 years
- Avg HCC Risk Score
- 2.23
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 31, 65-74: 106, 75-84: 79, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Maleka Ahmed, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Letrozole
Letrozole
156 claims
- Ondansetron Hcl
Ondansetron Hcl
70 claims
- Prochlorperazine M… 60
Prochlorperazine Maleate
60 claims
- Xtandi 56
Xtandi
56 claims
- Brukinsa 47
Brukinsa
47 claims
- Exemestane 47
Exemestane
47 claims
- Alendronate Sodium 42
Alendronate Sodium
42 claims
- Lenalidomide 42
Lenalidomide
42 claims
| Drug | Claims |
|---|---|
| Letrozole | 156 |
| Ondansetron Hcl | 70 |
| Prochlorperazine Maleate | 60 |
| Xtandi Enzalutamide | 56 |
| Brukinsa Zanubrutinib | 47 |
| Exemestane | 47 |
| Alendronate Sodium | 42 |
| Lenalidomide | 42 |
| Potassium Chloride | 38 |
| Dexamethasone | 37 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Maleka Ahmed, MD fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Maleka Ahmed, MD's 1,351 claims are above the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ahmed, both outside North Carolina so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Ahmed.
One of 108 Medical Oncology Physician providers enrolled in North Carolina, 5 are shown here.
Dr. Amy Abernethy
M.D.
Durham, NC
Dr. Neeraj Agrawal
MD
Raleigh, NC
Laura Alder
Durham, NC
Dr. Carey Anders
M.D.
Chapel Hill, NC
Dr. Andrew Armstrong
MD
Durham, NC
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Maleka Ahmed, MD's specialty? ▼
Maleka Ahmed, MD specializes in Medical Oncology Physician and practices in Lumberton, North Carolina. Credentials: MD.
How much does Maleka Ahmed, MD prescribe under Medicare Part D? ▼
In 2024, Maleka Ahmed, MD wrote 1,351 Medicare Part D claims totaling $4.8M in drug costs for 228 beneficiaries.
Where is Maleka Ahmed, MD located? ▼
Maleka Ahmed, MD is located at 1200 PINE RUN DR, Lumberton, NC, 28358. Phone: (910) 671-5730.
What is Maleka Ahmed, MD's NPI number? ▼
Maleka Ahmed, MD's National Provider Identifier (NPI) is 1841286721, issued on 09/26/2005.
Does Maleka Ahmed, MD prescribe more brand-name or generic drugs? ▼
Maleka Ahmed, MD's prescribing is 24% brand-name and 76% generic drugs by claim count, with $4.1M in brand drug costs.
Does Maleka Ahmed, MD prescribe opioids? ▼
Yes, Maleka Ahmed, MD had 134 opioid claims in 2024 with an opioid prescribing rate of 9.9%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Maleka Ahmed, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Maleka Ahmed, MD's most frequently prescribed drugs include Letrozole, Ondansetron Hcl, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Maleka Ahmed, MD accept Medicare? ▼
Maleka Ahmed, MD appears in CMS Medicare data with 1,351 Part D claims and 228 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Maleka Ahmed, MD's credentials? ▼
Maleka Ahmed, MD's NPI is 1841286721 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.